IBM Cites Deliberate Strategy Shift as it Drops to Second Place in IFI Claims Patent Grant List for First Time in 29 Years

“While we will remain an intellectual property powerhouse with one of the strongest US patent portfolios, as part of our innovation strategy, focus means that we are taking a more selective approach to patenting.” – IBM

IFIThis week, patent data analytics firm IFI CLAIMS published its annual report of the top 50 U.S. patent recipients and the global 250 largest patent portfolios for 2022. The list provides a comprehensive snapshot of the patent landscape with insights into growing trends in the industry.

One of the most eye-catching details is Samsung taking the first spot for U.S. patent grants in 2022, ending IBM’s 29-year reign at the top. The difference between the two is also surprisingly wide, with a gap of nearly 2,000 patent grants.

According to an IFI press release, the number of U.S. patent grants was at its lowest since 2018 despite the number of patent applications reaching a record high. Since the beginning of the COVID-19 pandemic, the number of patent grants has decreased three years in a row.

Nonetheless, IFI has observed a rebounding trend, with only a 1% decline in patent grants year-on-year compared to a 7% decline in 2021.

“Everything was trending upward until COVID hit, but grants have been declining. This might be due to the fact the USPTO faces a growing backlog of applications, some 700,000 currently, up from 540,000 unexamined patents in 2018,” said Mike Baycroft, CEO of IFI CLAIMS Patent Services.

New Number One

According to an IBM blog, the change at the top is part of a strategy shift and change of focus from the tech multinational.

“While we will remain an intellectual property powerhouse with one of the strongest US patent portfolios, as part of our innovation strategy, focus means that we are taking a more selective approach to patenting,” said IBM Senior Vice President and Director of Research Darío Gil.

IBM’s focus is now on “hybrid cloud, data and AI, automation, security, semiconductors, and quantum computing.”

The new leader, Samsung, saw a modest year-on-year decline of 2%, while IBM saw a drop of nearly 50%.

Samsung’s placement marks the first time since 1993 that a firm other than IBM occupies the first overall position.

There may be more changes on the horizon as patent offices work through the backlog of patent applications caused by the pandemic.

“The continued growth in applications is encouraging for innovation. First comes the filing, then typically 12-18 months later the application becomes public, then in another 18 months the grant is issued, so we expect to see a post-COVID upturn in the next couple of years,” said Baycroft.

Samsung also edged closer to the number one spot in the IFI Global 250 list, which provides a snapshot of the top entities’ global patent holdings, including those held by subsidiaries. Samsung is about 2,000 patents behind Japanese firm Panasonic. The top 10 in this list is only made up of Asian firms.

Japan had the highest number of companies on the Global 250 list, making 37% of the companies, a healthy lead on the United States in second place at 22%.

Asian Tech Growth

Korean tech conglomerate Samsung’s ascendence to the number one spot is part of a growing trend observed over the past decade of technological innovation in Asia.

In the IFI Top 50, Asian firms received 14% more patents than companies in Western countries, significantly more than the 1% advantage in 2021.

Last year, the IFI noted that new insights into patent data made for a clearer picture of the number of patents in China, which is partially the reason for the apparent large gains in the region.

After Samsung and IBM, the next three biggest recipients of U.S. patent grants were also firms in Asia: Taiwan Semiconductor Manufacturing Co at number 3, followed by Huawei and Canon. The top 10 is made up of five Asian firms: two Korean, two Japanese, and one Chinese.

Additionally, 56% of U.S. patent grants went to foreign companies. American companies led among patent grantees with 142,703 patents, or 44% of all patents issued by the United States Patent and Trademark Office (USPTO), but the next three biggest foreign patent recipients were Asian: Japan (46,504), China (24,538), and South Korea (22,359).

China’s growth surpassed all other countries in the top five, with 19% yearly growth.

Many of the top U.S. firms had a noticeable drop in the rankings. In addition to IBM losing the top spot, GE (-11), Texas Instruments (-7), AT&T (-9), Boeing (-8), Ford (-4), Microsoft (-6), Intel (-2), and Apple (-2) all dropped spots in the rankings.

Fastest-Growing Technologies

In addition to monitoring the patent holdings of companies, the IFI also tracks the fastest growing tech sectors by classifying patent applications.

The most astonishing growth sector in 2022 for patent applications was undoubtedly autonomous vehicles. Technology for autonomous vehicles or self-driving cars had a compound annual growth rate (CAGR) of 64%, which vaulted this tech sector from outside the top 10 into the number one spot.

Toyota leads the world in patent applications in this sector, despite Toyota executives’ skepticism about the implementation of the technology in the near future.

The next top technologies include an array of sectors ranging from high-tech (quantum computers at 6, and machine learning at 9) to the vice of smoking with both electrical smoking devices and cigarettes making the list, at 5 and 7, respectively.

Despite the recent emphasis from the USPTO on spurring green technology, renewable energy and green technology did not see large growth in 2022.

In fact, technology related to earth drilling for obtaining oil, gas or water clocked in at third on the list.

“As far as patent activity is concerned, we’re not yet seeing a shift toward renewable energy, and some of the fast growing sub-technology areas are focused on improving and more efficiently harvesting traditional fossil fuel sources,” said Baycroft.

Image Source: Deposit Photos
Image ID: 67109949
Author: vectorguy 

Share

Warning & Disclaimer: The pages, articles and comments on IPWatchdog.com do not constitute legal advice, nor do they create any attorney-client relationship. The articles published express the personal opinion and views of the author as of the time of publication and should not be attributed to the author’s employer, clients or the sponsors of IPWatchdog.com.

Join the Discussion

2 comments so far.

  • [Avatar for Lab Jedor]
    Lab Jedor
    January 12, 2023 12:22 pm

    Any patent that is substantially subject to obviousness rejection or invalidation is currently worthless as many independent inventors have found. Most rejections and/or invalidations are hindsight reconstructions using a dictionary approach.

    Participating full force in the USPTO patent system has been a requirement for IBM to influence the system. Operation-wise, cost of prosecution and maintenance of patents has been like negligible noise. Thus, at limited expenses, IBM had great influence and substantial benefits on and from our patent system. I remember with gratitude Manny Schecter’s (IBM’s Chief Patent Counsel) IPWatchdog Post (May 8, 2018) on Eligibility and the RSA Patent. I believe that his opinion played a significant role on the USPTO’s Examples of Eligibility, which uses specifically the RSA Patent. So, I don’t want to imply that IBM’s influence has been bad.

    However, as the value and defensibility of patents approach zero, even a company like IBM has decided that enough is enough. IBM has reached the same conclusion that many independent inventors have made years ago.

    The only surprise is that it has taken so long.

  • [Avatar for Anon]
    Anon
    January 11, 2023 08:40 pm

    One IBM executive to another:

    “Dude, the investing community is getting wise to the fact that we file a literal ton of dross, and our portfolio is dogmeat, all to get this “most patents” thing.”

    The other executive replies:

    “Well, it’s time to pull back. Let’s see what spin marketing can come up with.”